Tenaya Therapeutics
TNYA
96 hedge funds and large institutions have $177M invested in Tenaya Therapeutics in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 12 closing their positions.
6,350% more call options, than puts
Call options by funds: $129K | Put options by funds: $2K
50% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 12
32% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 28
7% more funds holding
Funds holding: 90 → 96 (+6)
1.34% more ownership
Funds ownership: 71.35% → 72.69% (+1.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
40% less capital invested
Capital invested by funds: $293M → $177M (-$116M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$7.71M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.48M |
| 3 |
GTC
Ghost Tree Capital
New York
|
+$2.37M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.24M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$781K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.56M |
| 2 |
BlackRock
New York
|
-$2.59M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
-$1.15M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$691K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$665K |
TNYA Hedge Fund Activity: Q2 2024 in Review
96 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q2 2024, worth a combined $177M — down 40% from $293M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new TNYA positions and 12 closed out — a net gain of 6 holders — while 37 added to existing stakes and 28 trimmed.
The largest buyer was RA Capital Management, adding an estimated $7.71M. The largest seller was Fidelity Investments, cutting an estimated $6.56M.
- 96 institutional investors held Tenaya Therapeutics (TNYA) as of Q2 2024, up from 90 in Q1 2024.
- Funds reported $177M of Tenaya Therapeutics stock for Q2 2024, down 40% quarter-over-quarter.
- 18 funds opened new Tenaya Therapeutics positions in Q2 2024 and 12 closed out, a net change of +6 holders.
- The largest Tenaya Therapeutics buyer in Q2 2024 was RA Capital Management, an estimated $7.71M added.
- The largest Tenaya Therapeutics seller in Q2 2024 was Fidelity Investments, an estimated $6.56M sold.
Based on aggregated 13F filings for Q2 2024.